BAUSCH + LOMB CORP (BLCO.CA) Fundamental Analysis & Valuation

TSX:BLCO • CA0717051076

Current stock price

21.31 CAD
-0.67 (-3.05%)
Last:

This BLCO.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. BLCO.CA Profitability Analysis

1.1 Basic Checks

  • BLCO had positive earnings in the past year.
  • BLCO had a positive operating cash flow in the past year.
  • In multiple years BLCO reported negative net income over the last 5 years.
  • BLCO had a positive operating cash flow in 4 of the past 5 years.
BLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFBLCO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • BLCO's Return On Assets of -2.57% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
  • With an excellent Return On Equity value of -5.58%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Return On Invested Capital of BLCO (1.12%) is better than 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BLCO is in line with the industry average of 1.12%.
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROIC 1.12%
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.23%
ROIC(5y)1.6%
BLCO.CA Yearly ROA, ROE, ROICBLCO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 -4

1.3 Margins

  • The Operating Margin of BLCO (3.69%) is better than 100.00% of its industry peers.
  • BLCO's Operating Margin has declined in the last couple of years.
  • The Gross Margin of BLCO (59.81%) is better than 70.59% of its industry peers.
  • BLCO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.69%
PM (TTM) N/A
GM 59.81%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
BLCO.CA Yearly Profit, Operating, Gross MarginsBLCO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

4

2. BLCO.CA Health Analysis

2.1 Basic Checks

  • BLCO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for BLCO has been increased compared to 1 year ago.
  • Compared to 5 years ago, BLCO has more shares outstanding
  • BLCO has a worse debt/assets ratio than last year.
BLCO.CA Yearly Shares OutstandingBLCO.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
BLCO.CA Yearly Total Debt VS Total AssetsBLCO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • Based on the Altman-Z score of 0.84, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.84, BLCO belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
  • A Debt/Equity ratio of 0.78 indicates that BLCO is somewhat dependend on debt financing.
  • BLCO's Debt to Equity ratio of 0.78 is fine compared to the rest of the industry. BLCO outperforms 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACC0.12
WACC9.69%
BLCO.CA Yearly LT Debt VS Equity VS FCFBLCO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that BLCO should not have too much problems paying its short term obligations.
  • The Current ratio of BLCO (1.55) is better than 88.24% of its industry peers.
  • BLCO has a Quick Ratio of 1.04. This is a normal value and indicates that BLCO is financially healthy and should not expect problems in meeting its short term obligations.
  • BLCO has a Quick ratio of 1.04. This is amongst the best in the industry. BLCO outperforms 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.04
BLCO.CA Yearly Current Assets VS Current LiabilitesBLCO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

4

3. BLCO.CA Growth Analysis

3.1 Past

  • The earnings per share for BLCO have decreased strongly by -19.35% in the last year.
  • The Revenue has been growing slightly by 6.47% in the past year.
  • Measured over the past years, BLCO shows a quite strong growth in Revenue. The Revenue has been growing by 8.38% on average per year.
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%

3.2 Future

  • Based on estimates for the next years, BLCO will show a very strong growth in Earnings Per Share. The EPS will grow by 29.28% on average per year.
  • The Revenue is expected to grow by 5.41% on average over the next years.
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue Next Year7.01%
Revenue Next 2Y6.29%
Revenue Next 3Y5.98%
Revenue Next 5Y5.41%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLCO.CA Yearly Revenue VS EstimatesBLCO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
BLCO.CA Yearly EPS VS EstimatesBLCO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0.5 1 1.5 2

5

4. BLCO.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • BLCO is valuated quite expensively with a Price/Earnings ratio of 30.88.
  • Based on the Price/Earnings ratio, BLCO is valued cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of BLCO to the average of the S&P500 Index (24.89), we can say BLCO is valued slightly more expensively.
  • Based on the Price/Forward Earnings ratio of 19.02, the valuation of BLCO can be described as rather expensive.
  • BLCO's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLCO is cheaper than 100.00% of the companies in the same industry.
  • BLCO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.88
Fwd PE 19.02
BLCO.CA Price Earnings VS Forward Price EarningsBLCO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than BLCO, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.67
BLCO.CA Per share dataBLCO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • BLCO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BLCO has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as BLCO's earnings are expected to grow with 40.86% in the coming years.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y47.88%
EPS Next 3Y40.86%

0

5. BLCO.CA Dividend Analysis

5.1 Amount

  • No dividends for BLCO!.
Industry RankSector Rank
Dividend Yield 0%

BLCO.CA Fundamentals: All Metrics, Ratios and Statistics

BAUSCH + LOMB CORP

TSX:BLCO (3/27/2026, 7:00:00 PM)

21.31

-0.67 (-3.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-18
Earnings (Next)N/A
Inst Owners10.27%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap7.57B
Revenue(TTM)5.10B
Net Income(TTM)-360.00M
Analysts71.58
Price Target25.69 (20.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.14%
Min EPS beat(2)-10.76%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)-90.21%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)-43.92%
EPS beat(12)8
Avg EPS beat(12)-25.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.31%
Revenue beat(12)5
Avg Revenue beat(12)0.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.91%
PT rev (3m)13.33%
EPS NQ rev (1m)-10.43%
EPS NQ rev (3m)-32.73%
EPS NY rev (1m)0.36%
EPS NY rev (3m)1.37%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)0.81%
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 30.88
Fwd PE 19.02
P/S 1.07
P/FCF N/A
P/OCF 19.28
P/B 0.85
P/tB N/A
EV/EBITDA 16.67
EPS(TTM)0.69
EY3.24%
EPS(NY)1.12
Fwd EY5.26%
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)1.11
OCFY5.19%
SpS19.93
BVpS25.19
TBVpS-6.21
PEG (NY)0.5
PEG (5Y)N/A
Graham Number19.77
Profitability
Industry RankSector Rank
ROA -2.57%
ROE -5.58%
ROCE 1.55%
ROIC 1.12%
ROICexc 1.16%
ROICexgc 3.68%
OM 3.69%
PM (TTM) N/A
GM 59.81%
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-1.02%
ROE(3y)-4.76%
ROE(5y)-2.45%
ROIC(3y)1.23%
ROIC(5y)1.6%
ROICexc(3y)1.26%
ROICexc(5y)1.65%
ROICexgc(3y)4.19%
ROICexgc(5y)5.55%
ROCE(3y)1.7%
ROCE(5y)2.22%
ROICexgc growth 3Y-15.27%
ROICexgc growth 5Y-11.42%
ROICexc growth 3Y-14.77%
ROICexc growth 5Y-9.61%
OM growth 3Y-17.35%
OM growth 5Y-14.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y-0.82%
F-Score3
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 8.28
Cap/Depr 82.9%
Cap/Sales 6.84%
Interest Coverage 0.49
Cash Conversion 46.47%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.04
Altman-Z 0.84
F-Score3
WACC9.69%
ROIC/WACC0.12
Cap/Depr(3y)65.67%
Cap/Depr(5y)57.94%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28%
EPS Next Y61.57%
EPS Next 2Y47.88%
EPS Next 3Y40.86%
EPS Next 5Y29.28%
Revenue 1Y (TTM)6.47%
Revenue growth 3Y10.62%
Revenue growth 5Y8.38%
Sales Q2Q%9.77%
Revenue Next Year7.01%
Revenue Next 2Y6.29%
Revenue Next 3Y5.98%
Revenue Next 5Y5.41%
EBIT growth 1Y-7.39%
EBIT growth 3Y-8.57%
EBIT growth 5Y-6.91%
EBIT Next Year65.28%
EBIT Next 3Y27.94%
EBIT Next 5Y20.35%
FCF growth 1Y-11.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.98%
OCF growth 3Y-6.39%
OCF growth 5Y-11.52%

BAUSCH + LOMB CORP / BLCO.CA Fundamental Analysis FAQ

What is the fundamental rating for BLCO stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA.


What is the valuation status of BAUSCH + LOMB CORP (BLCO.CA) stock?

ChartMill assigns a valuation rating of 5 / 10 to BAUSCH + LOMB CORP (BLCO.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for BAUSCH + LOMB CORP?

BAUSCH + LOMB CORP (BLCO.CA) has a profitability rating of 6 / 10.


What is the financial health of BAUSCH + LOMB CORP (BLCO.CA) stock?

The financial health rating of BAUSCH + LOMB CORP (BLCO.CA) is 3 / 10.